Anbio Biotechnology (NNNN) Receivables (2023 - 2025)
Anbio Biotechnology (NNNN) posted quarterly Receivables of $3.7 million for Q4 2025, up 243.44% year-over-year from $1.1 million in Q4 2024, and down 100.0% quarter-over-quarter from $3716.4 billion in Q2 2025.
Anbio Biotechnology (NNNN) Receivables (2023 - 2025) Analysis & Trends
Anbio Biotechnology (NNNN) has reported Receivables for 3 consecutive years, with $3.7 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Receivables rose 243.44% year-over-year to $3.7 million; the TTM figure through Dec 2025 stood at $3.7 million (up 243.44% YoY), while the FY2025 annual figure was $3.7 million, up 243.44% from the prior year.
- Receivables declined to $3.7 million in Q4 2025 per NNNN's latest filing, from $3716.4 billion in the prior quarter.
- Across five years, Receivables topped out at $3716.4 billion in Q2 2025 and bottomed at $1.1 million in Q4 2024.
- Historically, Receivables has averaged $929.1 billion across 3 years, with a median of $2.8 million in 2023.
- Annual changes were most pronounced in 2024 — Receivables tumbled 43.51% — and 2025, when it surged 243.44%.
- Anbio Biotechnology's Receivables stood at $1.9 million in 2023, then plunged by 43.51% to $1.1 million in 2024, then soared by 243.44% to $3.7 million in 2025.
- Business Quant data shows NNNN's Receivables at $3.7 million in Q4 2025, $3716.4 billion in Q2 2025, and $1.1 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.68 Bn | 129.47 Bn | 1.96 Bn | 1.67 Bn |
| 2 | Becton Dickinson | 52.46 Bn | 51.59 Bn | 2.32 Bn | 2.36 Bn |
| 3 | Alcon | 35.84 Bn | 34.49 Bn | 1.68 Bn | 2.08 Bn |
| 4 | Resmed | 33.87 Bn | 32.40 Bn | 861.22 Mn | 1.08 Bn |
| 5 | Medline | 28.95 Bn | 26.27 Bn | 2.22 Bn | 3.66 Bn |
| 6 | West Pharmaceutical Services | 25.14 Bn | 24.71 Bn | 329.20 Mn | 712.00 Mn |
| 7 | Solventum | 15.35 Bn | 14.95 Bn | 1.29 Bn | 1.43 Bn |
| 8 | Cooper Companies | 14.90 Bn | 14.77 Bn | 735.40 Mn | 809.20 Mn |
| 9 | Baxter International | 13.66 Bn | 11.51 Bn | 1.03 Bn | 1.92 Bn |
| 10 | Anbio Biotechnology | 303.08 Mn | 291.18 Mn | - | 3.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.66 Mn |
| Jun 30, 2025 | 3,716.38 Bn |
| Dec 31, 2024 | 1.06 Mn |
| Dec 31, 2023 | 1.88 Mn |